1.Warm bath cure for pain With special reference to consecutive bathing effect on equivocal complaints.
Masahiro KAWABATA ; Tatsushi ITO ; Naoya ITO ; Hideto KANEKO ; Hiroaki TACHIHARA
The Journal of The Japanese Society of Balneology, Climatology and Physical Medicine 1990;53(2):109-114
Two patients with spondylosis deformans and three patients with psychosomatic disease were treated by partial bathing with artificial spring of sodium sulfate. Fifteen minutes a day of bathing in artificial spring water prepared by dissolving 1000mg of sodium sulfate into 1 liter of 38°C-tap water was continued for one month.
Based on the findings on thermography, temperature changes were classified into four types. Correlation was found in three types as follows: p<0.01 in the crossing type, p<0.01 in the converging type, p<0.001 and p<0.05 in the ascending type. No correlation was found in the diffusing type. Plethysmography revealed a significant difference in the converging type and also a difference of p<0.01 in the diffusing type. MCV disclosed a slower change in temperature on the affected side than on the normal side. Blood gas analysis revealed a slight increase in PO2, SATO2 after one month of bathing. Subjective symptoms were improved from point 9 to point 3 to 4 on the VAS scale. Numbness changed from the trembling stage to the slightly smarting sensation stage. Psychroesthesia disappeared from all patients.
A combination of nerve block therapy and warm bath cure with sodium sulfate brought good therapeutic results in patients with chronic pain including psychosomatic disease.
2.Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
Kensuke SAKURAI ; Shigeru FURUKAWA ; Takehiko KATSURADA ; Shinsuke OTAGIRI ; Kana YAMANASHI ; Kazunori NAGASHIMA ; Reizo ONISHI ; Keiji YAGISAWA ; Haruto NISHIMURA ; Takahiro ITO ; Atsuo MAEMOTO ; Naoya SAKAMOTO
Intestinal Research 2022;20(1):78-89
Background/Aims:
Inflammatory bowel disease (IBD) patients frequently have zinc deficiency. IBD patients with zinc deficiency have higher risks of IBD-related hospitalization, complications, and requiring surgery. This study aimed to examine the effectiveness of zinc acetate hydrate (ZAH; Nobelzin) in IBD patients with zinc deficiency.
Methods:
IBD patients with zinc deficiency who received ZAH from March 2017 to April 2020 were registered in this two-center, retrospective, observational study. Changes in serum zinc levels and disease activity (Crohn’s Disease Activity Index [CDAI]) before and after ZAH administration were analyzed.
Results:
Fifty-one patients with Crohn’s disease (CD, n = 40) or ulcerative colitis (UC, n = 11) were registered. Median serum zinc level and median CDAI scores significantly improved (55.5–91.0 μg/dL, P< 0.001; 171.5–129, P< 0.001, respectively) in CD patients 4 weeks after starting ZAH administration. Similarly, median serum zinc levels and CDAI scores significantly improved (57.0–81.0 μg/dL, P< 0.001; 177–148, P= 0.012, respectively) 20 weeks after starting ZAH administration. Similar investigations were conducted in groups where no treatment change, other than ZAH administration, was implemented; significant improvements were observed in both serum zinc level and CDAI scores. Median serum zinc levels in UC patients 4 weeks after starting ZAH administration significantly improved from 63.0 to 94.0 μg/dL (P= 0.002), but no significant changes in disease activity were observed. One patient experienced side effects of abdominal discomfort and nausea.
Conclusions
ZAH administration is effective in improving zinc deficiency and may contribute to improving disease activity in IBD.
3.Relationship between Health Knowledge and Willingness to Use Online Medication Guidance─Iwaki Health Promotion Project Research Report─
Masakiyo KUDO ; Yoshihito KON ; Sachiko KANAZAWA ; Shinichi OBARA ; Kazuhiro HOSOI ; Kazufumi TERUI ; Junichi NAKAGAWA ; Masanori ABO ; Hiromasa TSUYAMA ; Rui HYODO ; Naoya AIUCHI ; Saki YONAGA ; Takahiro HATAYAMA ; Seiya KAWAGUCHI ; Kozue ITO ; Keigo SAITO ; Iku ABUKAWA ; Satoshi YOKOYAMA ; Takamasa SAKAI ; Fumiko OHTSU ; Tatsuya MIKAMI ; Shigeyuki NAKAJI ; Takenori NIIOKA
Japanese Journal of Social Pharmacy 2024;43(2):68-75
People with high health knowledge tend to use information and communication technology (ICT) to obtain, maintain, and promote information necessary for health management. Therefore, experts hypothesize that improving health knowledge will increase the use of online medication guidance via ICT. In this study, we investigated the relationship between health knowledge and willingness to use online medication guidance among Iwaki Health Promotion Project health checkup subjects. The 736 examinees participating in this project in 2022 were surveyed on age, gender, number of people living with them, whether they exercise, drink alcohol, or smoke, whether they use smartphones, whether they use medication registers, their health knowledge score, and whether they take any medications. The presence/absence of desire for online medication guidance (1/0) was used as the objective variable to identify influencing factors. Univariate and multivariate analyses showed that independence was found for four factors: age (OR: 0.975, P<0.001), gender (male) (OR: 1.914, P<0.001), smartphone use (OR: 2.156, P=0.004) and health knowledge score (OR: 1.405, P<0.001). This study found that health knowledge plays a role in the intention to use online medication guidance. In order to improve health knowledge, it will be necessary to enhance skills to obtain and use high-quality health information and to improve the environment for using ICT-based communication devices.